Kenneth J. Cavanaugh, Jr., PhD

Deputy Director, Office of Cardiovascular Devices
U.S. Food and Drug Administration
Silver Spring, Maryland, United States

No relationships to disclose

Presentation(s):

• SESSION III: CHALLENGES AND PATHS FORWARD FOR LONG-TERM AND POST-MARKET FOLLOW UP: DEVICE PATIENTS

  Saturday, March 9, 2024
  3:05 PM – 4:30 PM ET

• Discussion Panel

  Saturday, March 9, 2024
  4:05 PM – 4:30 PM ET

• FDA Japan | Session One [Non-CME]

  Sunday, March 10, 2024
  8:00 AM – 11:40 AM ET

• CDRH International Update

  Sunday, March 10, 2024
  8:15 AM – 8:30 AM ET

• Panel Discussion

  Sunday, March 10, 2024
  11:00 AM – 11:30 AM ET

• FDA Japan | Session Two [Non-CME]

  Monday, March 11, 2024
  8:00 AM – 12:00 PM ET